Trimethoprim-sulfamethoxazole-induced linear iga bullous disease presenting as toxic epidermal necrolysis

6Citations
Citations of this article
12Readers
Mendeley users who have this article in their library.

Abstract

Background: Linear IgA bullous dermatosis (LABD) is an autoimmune blistering skin disorder characterized by linear IgA deposits along the dermoepidermal junction. Usually idiopathic, LABD can be drug-induced. Objective: To report the atypical characteristics of a case of trimethoprim-sulfamethoxazole-induced LABD presenting as toxic epidermal necrolysis (TEN). Methods: A 63-year-old woman treated with trimethoprim-sulfamethoxazole for Pneumocystis jirovecii infection developed a generalized maculopapular rash with herpetiform lesions, rosette-like lesions, and tense bullae with Nikolsky sign. Results: Anti-basement membrane zone antibodies were negative, but immunoblot revealed a 160 kDa band corresponding to subepidermal class IgA desmoglein 1. Skin biopsy specimens revealed a subepidermal bulla and direct immunofluorescence showed linear IgA deposition along the basement membrane zone. A diagnosis of toxic epidermal necrolysis was excluded and replaced by trimethoprim-sulfamethoxazole-induced LABD. Conclusion: We report a case of trimethoprim-sulfamethoxazole-induced LABD with a 160 kDa IgA desmoglein 1 found by immunoblotting analysis, probably by epitope spreading.

Cite

CITATION STYLE

APA

Baltazard, T., Dhaille, F., Duvert-Lehembre, S., Lok, C., & Chaby, G. (2017). Trimethoprim-sulfamethoxazole-induced linear iga bullous disease presenting as toxic epidermal necrolysis. Dermatology Online Journal, 23(8). https://doi.org/10.5070/d3238036012

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free